Moreover, we found that eMDSCs suppress the ARID1A expression to promote EMT in luminal A breast cancer cells, which might provide a new light on developing novel treatment regimens for relapsed luminal A breast cancer after conventional therapies. Here, ARID1A is linked to breast carcinoma.